Novocure (NVCR) Misses Q1 EPS by 9c

Novocure (NASDAQ: NVCR) reported Q1 EPS of ($0.42), $0.09 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $13.1 million versus the consensus estimate of $23.65 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• JPMorgan Upgrades Wanhua Chemical Group (600309:CH) to Overweight
• Kura Sushi (KRUS) Tops Q3 EPS by 3c; offers outlook